Sitemap
Pages
Posts
- Ben Watt Joins SERB and BTG as Group CFO
- SERB acquires the rights to Xermelo® outside US and Japan for Carcinoid Syndrome Diarrhoea
- SERB acquires Veriton Pharma
- SERB completes acquisition of BTG Specialty Pharmaceuticals to create a global leader in critical care medicines
- SERB Pharmaceuticals licenses Soligenix antigen to develop ricin antidote
- SERB receives positive CHMP opinion for Voraxaze® (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity
- Why We Are Joining the UN Global Compact as Part of Our Broader Strategy
